124 related articles for article (PubMed ID: 15373023)
1. [An end to scurrilous recommendations on the new regulation. What is still allowed on the insurance form?].
Schmidt K
MMW Fortschr Med; 2004 Apr; 146(15):60-2. PubMed ID: 15373023
[No Abstract] [Full Text] [Related]
2. [Family physicians resist high prescription risk].
Schmidt K
MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
[No Abstract] [Full Text] [Related]
3. [Does red-green destroy phytotherapy?].
Krankenpfl J; 2003; 41(4-6):111. PubMed ID: 12929322
[No Abstract] [Full Text] [Related]
4. [Vascular specialists in a campaign against positive list. Threat of deficient care for 4.5 million vascular patients].
Krankenpfl J; 2003; 41(4-6):120. PubMed ID: 12929329
[No Abstract] [Full Text] [Related]
5. [No reimbursement for non-prescription medicine. Expensive savings plan?].
MMW Fortschr Med; 2003 Aug; 145(33-34):57. PubMed ID: 14526581
[No Abstract] [Full Text] [Related]
6. [The negative list--a false step in the right direction].
Rempen E
Fortschr Med; 1982 Dec; 100(45):2093-5. PubMed ID: 7173793
[No Abstract] [Full Text] [Related]
7. [Psychopharmacological regulations. Results and commentary to the report on drug regulations 2002].
Fritze J
Nervenarzt; 2003 Mar; 74(3):301-6. PubMed ID: 12722759
[No Abstract] [Full Text] [Related]
8. [New institute for additional drug evaluation. Do we really need another barrier?].
Schmidt K
MMW Fortschr Med; 2003 Jul; 145(29-30):55-6. PubMed ID: 12958781
[No Abstract] [Full Text] [Related]
9. [Limiting prescribing freedom in the hospital].
Jansen C
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):635-7; discussion 638. PubMed ID: 9527459
[TBL] [Abstract][Full Text] [Related]
10. [European court. Drug budgets of physicians remain reduced].
MMW Fortschr Med; 2004 Mar; 146(13):57. PubMed ID: 15219133
[No Abstract] [Full Text] [Related]
11. PhRMA challenges Maine's novel Rx law.
Tieman J
Mod Healthc; 2000 Aug; 30(34):12-3. PubMed ID: 11185156
[No Abstract] [Full Text] [Related]
12. [Drug guidelines. Put on hold for the next 4 years. Interview by Peter Jentsch].
Bausch J
MMW Fortschr Med; 1999 Aug; 141(33):51-2. PubMed ID: 10766543
[No Abstract] [Full Text] [Related]
13. Can a health care system change?
Lexchin J
CMAJ; 1997 Sep; 157(5):507-8. PubMed ID: 9294383
[No Abstract] [Full Text] [Related]
14. [Only what happens in your own practice counts. No fear of collective regress].
Schmidt KA
MMW Fortschr Med; 2000 Nov; 142(44):47. PubMed ID: 11107807
[No Abstract] [Full Text] [Related]
15. [Prerequisites in prescribing practice: physician decision processes].
Dierks C
Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):620-4. PubMed ID: 9527454
[TBL] [Abstract][Full Text] [Related]
16. [Development of clinical drug trials and the formal, legal and financial scope].
Wingen FJ; Beinhauer KG
Internist (Berl); 2002 Apr; 43(4):460, 463-8. PubMed ID: 12053402
[No Abstract] [Full Text] [Related]
17. [Sequlae of "silent rationing". Substantial deficits in drug management].
MMW Fortschr Med; 2001 Jan; 143(4):43. PubMed ID: 11219284
[No Abstract] [Full Text] [Related]
18. [Prevention and early therapy play too minor a role in our health care system].
Rothe HJ
Med Klin (Munich); 2003 Oct; 98 Suppl 1():22-3. PubMed ID: 14694840
[No Abstract] [Full Text] [Related]
19. [Positive list of drugs and osteoporosis].
Krankenpfl J; 2003; 41(4-6):113. PubMed ID: 12929324
[No Abstract] [Full Text] [Related]
20. Over-the-counter drugs as a new managed care benefit.
Scheur BS; Aaron RM
Med Interface; 1997 Feb; 10(2):88-94. PubMed ID: 10164797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
